Regulation of angiogenesis by scatter factor - PubMed (original) (raw)
Review
Regulation of angiogenesis by scatter factor
E M Rosen et al. EXS. 1997.
Abstract
Scatter factor (SF, hepatocyte growth factor) is a cytokine that stimulates motility, proliferation, and morphogenesis of epithelia. These responses are transduced through a tyrosine kinase receptor that is encoded by a proto-oncogene (c-met). SF is a potent angiogenic molecule, and its angiogenic activity is mediated, in part, through direct actions on endothelial cells. These include stimulation of cell motility, proliferation, protease production, invasion, and organization into capillary-like tubes. SF also stimulates the proliferation of smooth muscle cells and pericytes, cell types that also participate in the formation of capillaries and other microvessels. SF is chronically overexpressed in tumors, and it is postulated SF may function as a tumor angiogenesis factor. SF production in tumors may be due, in part, to an abnormal tumor: stroma interaction in which tumor cells secrete soluble proteins (SF-inducing factors) that stimulate stromal cell SF production and in part to autocrine production by the tumor cells themselves. Recent studies suggest a linkage between tumor suppressors (anti-oncogenes) and inhibition of angiogenesis. We hypothesize that tumor suppressor gene mutations may contribute to activation of an SF-->c-met signalling pathway, leading to an invasive and angiogenic tumor phenotype. Modulation of this pathway may provide clinically useful methods of enhancing or inhibiting angiogenesis.
Similar articles
- Scatter factor and angiogenesis.
Rosen EM, Goldberg ID. Rosen EM, et al. Adv Cancer Res. 1995;67:257-79. doi: 10.1016/s0065-230x(08)60715-0. Adv Cancer Res. 1995. PMID: 8571817 Review. - HGF/SF in angiogenesis.
Rosen EM, Lamszus K, Laterra J, Polverini PJ, Rubin JS, Goldberg ID. Rosen EM, et al. Ciba Found Symp. 1997;212:215-26; discussion 227-9. doi: 10.1002/9780470515457.ch14. Ciba Found Symp. 1997. PMID: 9524773 Review. - Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, Rosen EM. Lamszus K, et al. Lab Invest. 1997 Mar;76(3):339-53. Lab Invest. 1997. PMID: 9121117 - Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo.
Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P. Rosen EM, et al. Symp Soc Exp Biol. 1993;47:227-34. Symp Soc Exp Biol. 1993. PMID: 8165567 - Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
Lamszus K, Laterra J, Westphal M, Rosen EM. Lamszus K, et al. Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):517-30. doi: 10.1016/s0736-5748(99)00008-8. Int J Dev Neurosci. 1999. PMID: 10571413 Review.
Cited by
- Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review.
Han Z, Wu Y, Wang K, Xiao Y, Cheng Z, Sun X, Shen B. Han Z, et al. EJNMMI Res. 2017 Dec;7(1):41. doi: 10.1186/s13550-017-0286-z. Epub 2017 May 8. EJNMMI Res. 2017. PMID: 28485003 Free PMC article. Review. - New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.
Ballara SC, Miotla JM, Paleolog EM. Ballara SC, et al. Int J Exp Pathol. 1999 Oct;80(5):235-50. doi: 10.1046/j.1365-2613.1999.00129.x. Int J Exp Pathol. 1999. PMID: 10607014 Free PMC article. Review. - Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.
Nishio M, Horiike A, Nokihara H, Horinouchi H, Nakamichi S, Wakui H, Ohyanagi F, Kudo K, Yanagitani N, Takahashi S, Kuboki Y, Yamamoto N, Yamada Y, Abe M, Tahata T, Tamura T. Nishio M, et al. Invest New Drugs. 2015 Jun;33(3):632-40. doi: 10.1007/s10637-015-0227-5. Epub 2015 Mar 18. Invest New Drugs. 2015. PMID: 25777467 Clinical Trial. - Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies.
Paleolog EM, Fava RA. Paleolog EM, et al. Springer Semin Immunopathol. 1998;20(1-2):73-94. doi: 10.1007/BF00832000. Springer Semin Immunopathol. 1998. PMID: 9836370 No abstract available. - The rationale and future potential of angiogenesis inhibitors in neoplasia.
Gasparini G. Gasparini G. Drugs. 1999 Jul;58(1):17-38. doi: 10.2165/00003495-199958010-00003. Drugs. 1999. PMID: 10439927 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous